[go: up one dir, main page]

AU2013204740A1 - Methods of treating cancer using angiogenin or an angiogenin agonist - Google Patents

Methods of treating cancer using angiogenin or an angiogenin agonist

Info

Publication number
AU2013204740A1
AU2013204740A1 AU2013204740A AU2013204740A AU2013204740A1 AU 2013204740 A1 AU2013204740 A1 AU 2013204740A1 AU 2013204740 A AU2013204740 A AU 2013204740A AU 2013204740 A AU2013204740 A AU 2013204740A AU 2013204740 A1 AU2013204740 A1 AU 2013204740A1
Authority
AU
Australia
Prior art keywords
angiogenin
methods
treating cancer
agonist
angiogenin agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2013204740A
Other versions
AU2013204740C1 (en
AU2013204740B2 (en
Inventor
Andrew Brown
Peter Hobman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agriculture Victoria Services Pty Ltd
Saputo Dairy Australia Pty Ltd Canada
Original Assignee
Agriculture Victoria Services Pty Ltd
Saputo Dairy Australia Pty Ltd Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agriculture Victoria Services Pty Ltd, Saputo Dairy Australia Pty Ltd Canada filed Critical Agriculture Victoria Services Pty Ltd
Priority claimed from AU2013204740A external-priority patent/AU2013204740C1/en
Priority to AU2013204740A priority Critical patent/AU2013204740C1/en
Priority to EP13787726.2A priority patent/EP2846820A4/en
Priority to JP2015510577A priority patent/JP2015517471A/en
Priority to RU2014149807A priority patent/RU2014149807A/en
Priority to CN201380037180.4A priority patent/CN104470533A/en
Priority to BR112014027967A priority patent/BR112014027967A2/en
Priority to US14/399,852 priority patent/US9839676B2/en
Priority to PCT/AU2013/000478 priority patent/WO2013166555A1/en
Priority to CA2872850A priority patent/CA2872850A1/en
Priority to NZ631749A priority patent/NZ631749A/en
Publication of AU2013204740A1 publication Critical patent/AU2013204740A1/en
Application granted granted Critical
Publication of AU2013204740B2 publication Critical patent/AU2013204740B2/en
Publication of AU2013204740C1 publication Critical patent/AU2013204740C1/en
Priority to JP2018023212A priority patent/JP2018100288A/en
Assigned to Saputo Dairy Australia Pty Limited, AGRICULTURE VICTORIA SERVICES PTY LTD reassignment Saputo Dairy Australia Pty Limited Request for Assignment Assignors: AGRICULTURE VICTORIA SERVICES PTY LTD, MURRAY GOULBURN CO-OPERATIVE CO. LIMITED
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

AU2013204740A 2012-05-10 2013-04-12 Methods of treating cancer using angiogenin or an angiogenin agonist Ceased AU2013204740C1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
AU2013204740A AU2013204740C1 (en) 2012-05-10 2013-04-12 Methods of treating cancer using angiogenin or an angiogenin agonist
PCT/AU2013/000478 WO2013166555A1 (en) 2012-05-10 2013-05-10 Methods of treating cancer using angiogenin or an angiogenin agonist
NZ631749A NZ631749A (en) 2012-05-10 2013-05-10 Methods of treating cancer using angiogenin or an angiogenin agonist
JP2015510577A JP2015517471A (en) 2012-05-10 2013-05-10 Cancer treatment method
RU2014149807A RU2014149807A (en) 2012-05-10 2013-05-10 WAYS OF TREATMENT OF MALIGNANT NEW FORMATIONS USING ANGIOGENIN OR AN ANGIOGENIN AGONIST
CN201380037180.4A CN104470533A (en) 2012-05-10 2013-05-10 Methods of treating cancer using angiogenin or an angiogenin agonist
BR112014027967A BR112014027967A2 (en) 2012-05-10 2013-05-10 cancer treatment methods using angiogenin or an angiogenin agonist
US14/399,852 US9839676B2 (en) 2012-05-10 2013-05-10 Methods of treating cancer using angiogenin or an angiogenin agonist
EP13787726.2A EP2846820A4 (en) 2012-05-10 2013-05-10 Methods of treating cancer using angiogenin or an angiogenin agonist
CA2872850A CA2872850A1 (en) 2012-05-10 2013-05-10 Methods of treating cancer using angiogenin or an angiogenin agonist
JP2018023212A JP2018100288A (en) 2012-05-10 2018-02-13 Methods of treating cancer

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2012901918 2012-05-10
AU2012901918A AU2012901918A0 (en) 2012-05-10 Methods for treating cancer
AU2013204740A AU2013204740C1 (en) 2012-05-10 2013-04-12 Methods of treating cancer using angiogenin or an angiogenin agonist

Publications (3)

Publication Number Publication Date
AU2013204740A1 true AU2013204740A1 (en) 2013-12-12
AU2013204740B2 AU2013204740B2 (en) 2015-04-23
AU2013204740C1 AU2013204740C1 (en) 2015-10-01

Family

ID=49549993

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013204740A Ceased AU2013204740C1 (en) 2012-05-10 2013-04-12 Methods of treating cancer using angiogenin or an angiogenin agonist

Country Status (10)

Country Link
US (1) US9839676B2 (en)
EP (1) EP2846820A4 (en)
JP (2) JP2015517471A (en)
CN (1) CN104470533A (en)
AU (1) AU2013204740C1 (en)
BR (1) BR112014027967A2 (en)
CA (1) CA2872850A1 (en)
NZ (1) NZ631749A (en)
RU (1) RU2014149807A (en)
WO (1) WO2013166555A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009137880A1 (en) 2008-05-14 2009-11-19 Agriculture Victoria Services Pty Ltd Use of angiogenin or angiogenin agonists for treating diseases and disorders
AU2013204740C1 (en) 2012-05-10 2015-10-01 Agriculture Victoria Services Pty Ltd Methods of treating cancer using angiogenin or an angiogenin agonist
KR20160127076A (en) * 2014-03-06 2016-11-02 유니버시티 오브 써던 캘리포니아 Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623509B1 (en) 1987-11-19 1990-04-20 Centre Nat Rech Scient 17 KD PROTEIN WITH ANGIOGENIC ACTION, METHOD FOR ISOLATING IT FROM MAMMALIAN MILK, THERAPEUTIC COMPOSITIONS CONTAINING SAME, METHOD FOR DETECTION AND / OR DOSAGE AND IMMUNOLOGICAL REAGENTS FOR DETECTION AND DOSAGE OF ANGIOGENINS OF MAMMALS, AND OF THEIR FRAGMENTS
EP0620709B1 (en) 1992-01-15 1995-10-18 Campina Melkunie B.V. Process for isolating lactoferrin and lactoperoxidase from milk and milk products
JP3880063B2 (en) 1993-03-18 2007-02-14 シティミューン サイエンシーズ,インコーポレイテッド Compositions and methods for reducing the toxicity of biologically active agents
JP3112637B2 (en) 1994-09-30 2000-11-27 雪印乳業株式会社 Bone strengthener
JP2974604B2 (en) 1996-01-23 1999-11-10 雪印乳業株式会社 Basic protein composition, basic peptide composition and use thereof
JP3929088B2 (en) 1996-06-20 2007-06-13 雪印乳業株式会社 Bone formation promoter and bone resorption inhibitor
RU2110066C1 (en) 1996-12-27 1998-04-27 Московский государственный университет прикладной биотехнологии Method of quantitatively determining angiogenin in biological sample
NL1005677C2 (en) 1997-03-27 1998-09-29 Campina Melkunie Bv Method for recovering growth factors, or a composition containing one or more growth factors, from milk or a derivative thereof.
KR100236977B1 (en) * 1997-11-01 2000-01-15 윤재승 A fusion protein of hegf and human antiogenin, and process for preparing the same
CA2331620A1 (en) 1998-05-11 1999-11-18 The Endowment For Research In Human Biology, Inc. Use of neomycin for treating angiogenesis-related diseases
AU782394B2 (en) 1999-06-29 2005-07-21 J. Alexander Marchosky Compositions and methods for forming and strengthening bone
EP1217070A1 (en) 2000-12-22 2002-06-26 CellGenix Technologie Transfer GmbH Selective cytotoxic fusion proteins
TW200526779A (en) 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
RU2204262C2 (en) 2001-07-06 2003-05-20 Московский государственный университет прикладной биотехнологии Method for preparing biologically active protein concentrate enriched with pancreatic ribonuclease a, angiogenin and lysozyme from dairy ultrafiltrate
CN1161467C (en) * 2001-07-09 2004-08-11 中国人民解放军军事医学科学院生物工程研究所 Fusion protein with anti-tumor effect and application of the protein
JP4291967B2 (en) 2001-11-08 2009-07-08 雪印乳業株式会社 Skin collagen production promoter
EP1529054A4 (en) 2001-11-27 2005-12-28 Univ Washington THERAPEUTIC PROTEIN AND TREATMENTS
PL383616A1 (en) 2002-12-20 2008-04-14 Amgen Inc. Agents binding and inhibiting miostatin
JP4698935B2 (en) 2003-05-07 2011-06-08 雪印乳業株式会社 Skin collagen production promoter
WO2004106491A2 (en) 2003-05-22 2004-12-09 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Angiogenin-based hiv-1 therapies
US8114969B2 (en) * 2003-10-01 2012-02-14 Isis Innovation, Ltd. Immunotoxin derived from a recombinant human autoantibody and method of using thereof
EP1678123A1 (en) 2003-10-15 2006-07-12 Bayer HealthCare AG Tetrahydro-naphthalene and urea derivatives
US20050180957A1 (en) 2004-01-16 2005-08-18 Scharp David W. Method of using fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
US8147561B2 (en) 2004-02-26 2012-04-03 Endosphere, Inc. Methods and devices to curb appetite and/or reduce food intake
EP3006039B1 (en) 2004-03-02 2021-01-06 Acceleron Pharma Inc. Alk7 polypeptides for use in promoting fat loss
EP1765365A4 (en) * 2004-06-22 2008-02-20 Pro Pharmaceuticals Inc Compositions and methods ofr the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide
GB0425625D0 (en) 2004-11-22 2004-12-22 Royal College Of Surgeons Ie Treatment of disease
US20060251739A1 (en) 2005-05-04 2006-11-09 National Yang-Ming University Composition and method for treating autoimmune disease and mucosal disorder
US20090036369A1 (en) 2005-07-26 2009-02-05 Kirin Pharma Kabushiki Kaisha Anti-tumor agents comprising r-spondins
WO2007023479A2 (en) 2005-08-23 2007-03-01 Royal College Of Surgeons In Ireland Treatment of central nervous system injury
US7612041B2 (en) 2005-11-23 2009-11-03 Acceleron Pharma Inc. Isolated activin-binding ActRIIa polypeptide comprising the SEQ ID NO: 7 and uses for promoting bone growth
CA2633131A1 (en) 2005-12-21 2007-06-28 Viventia Biotech Inc. Novel cancer-associated antigen
AR060632A1 (en) 2006-04-26 2008-07-02 Genentech Inc PHOSFOINOSITIDE INHIBITING COMPOUNDS 3- KINASE AND METHODS OF USE
US8021659B2 (en) 2006-04-28 2011-09-20 Naidu Lp Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
US20070275036A1 (en) 2006-05-18 2007-11-29 Celldyne Biopharma, Llc Avian follistatin product
JP2009543868A (en) * 2006-07-17 2009-12-10 クインテセンス バイオサイエンシーズ インコーポレーティッド Methods and compositions for cancer treatment
CN101626693B (en) 2006-11-10 2014-05-14 墨累古尔本合作有限公司 Process for preparation of angiogenin
US7601689B2 (en) 2007-04-12 2009-10-13 Naidu Lp Angiogenin complexes (ANGex) and uses thereof
JP5384502B2 (en) * 2007-09-11 2014-01-08 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト Use of somatostatin-14 as a therapeutic agent
RU2010150934A (en) * 2008-05-14 2012-06-20 Эгрикалчер Виктория Сервисиз Пти Лтд (Au) ORAL DRUG
WO2009137880A1 (en) 2008-05-14 2009-11-19 Agriculture Victoria Services Pty Ltd Use of angiogenin or angiogenin agonists for treating diseases and disorders
WO2009137881A1 (en) 2008-05-14 2009-11-19 Agriculture Victoria Services Pty Ltd Angiogenin-enriched milk fractions
AU2013204721B2 (en) 2008-05-14 2016-08-18 Agriculture Victoria Services Pty Ltd Methods for treating cachexia
US20120328591A1 (en) * 2009-11-18 2012-12-27 Agriculture Victoria Services Pty Ltd Methods for improving oral delivery
WO2011060489A1 (en) 2009-11-18 2011-05-26 Murray Goulburn Co-Operative Co. Limited Transgenic non-human animals
US20130243728A9 (en) 2009-11-18 2013-09-19 Agriculture Victoria Services Pty Ltd Recombinant microorganisms
WO2013051767A1 (en) 2011-10-06 2013-04-11 중앙대학교 산학협력단 Novel use of angiogenin
AU2013204740C1 (en) 2012-05-10 2015-10-01 Agriculture Victoria Services Pty Ltd Methods of treating cancer using angiogenin or an angiogenin agonist

Similar Documents

Publication Publication Date Title
IL288181A (en) Methods of treating cancer
EP3071209A4 (en) Use of sting agonist as cancer treatment
EP3060207A4 (en) Methods and compositions for treating cancer
IL237791A0 (en) Method of treating cancer
EP3027192A4 (en) Methods for the treatment of solid tumors
EP2964028A4 (en) Compounds for treatment of cancer
EP3057594A4 (en) Method of treating cancer
EP2968254A4 (en) Methods of treating lung cancer
EP3077049A4 (en) Compositions and methods for treating vitiligo
EP2895206A4 (en) Method of treating cancer
EP2988659A4 (en) Improved methods of cancer detection
EP2970419B8 (en) Methods of treating colorectal cancer
EP2965086A4 (en) Methods of detecting prostate cancer
EP3008212A4 (en) Methods of treatment of cancer
SG11201508878WA (en) Methods of treating cancer
EP3004395A4 (en) Compositions and methods for treating cancer
EP3052102A4 (en) Compositions and methods for treating cancers
EP3074040A4 (en) Method of treating cancer
EP3057593A4 (en) Treatment for pancreatic cancer
EP3011013A4 (en) Methods for treatment of ovarian cancer
EP3082841A4 (en) Methods for treating an animal
ZA201507762B (en) Methods of treating cancer
EP2991650A4 (en) Methods for the treatment of cancer
AU2013204740A1 (en) Methods of treating cancer using angiogenin or an angiogenin agonist
EP2846820A4 (en) Methods of treating cancer using angiogenin or an angiogenin agonist